A detailed history of Bank Of Montreal transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 14,685 shares of SWTX stock, worth $547,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,685
Holding current value
$547,456
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$36.5 - $52.5 $536,002 - $770,962
14,685 New
14,685 $722,000
Q2 2022

Aug 11, 2022

BUY
$18.36 - $60.07 $568,205 - $1.86 Million
30,948 New
30,948 $785,000
Q4 2021

Feb 11, 2022

SELL
$53.3 - $75.84 $346,823 - $493,490
-6,507 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$62.66 - $88.26 $6.94 Million - $9.78 Million
-110,764 Reduced 94.45%
6,507 $450,000
Q2 2021

Aug 12, 2021

BUY
$67.45 - $85.63 $7.91 Million - $10 Million
117,271 New
117,271 $9.75 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $2.33B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.